Mouse Adenoviruses

The Mouse in Biomedical Research

Volumn 2, Issue , 2007, Pages 49-65

  Spindler, Katherine R ^a   Moore, Martin L ^b   Cauthen, Angela N ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Clayton College and State University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649851042     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369454-6/50030-3     Document Type: Chapter

References (153)

1. Ackrill A.M., Foster G.R., Laxton C.D., Flavell D.M., Stark G.R., Kerr I.M. Inhibition of the cellular response to interferons by products of the adenovirus type-5 E1A oncogene. Nucl. Acids Res. 1991, 19:4387-4393.
2. Antoine G., Aleström P., Schilling R., Pettersson U., Winnacker E.L. Defective expression of mouse adenovirus Fl in human cells. EMBO J. 1982, 1:453-459.
3. Ball A.O., Beard C.W., Redick S.D., Spindler K.R. Genome organization of mouse adenovirus type 1 early region 1: a novel transcription map. Virology 1989, 170:523-536.
4. Ball A.O., Beard C.W., Villegas P., Spindler K.R. Early region 4 sequence and biological comparison of two isolates of mouse adenovirus type 1. Virology 1991, 180:257-265.
5. Ball A.O., Williams M.E., Spindler K.R. Identification of mouse adenovirus type 1 early region 1: DNA sequence and a conserved transactivating function. J. Virol. 1988, 62:3947-3957.
6. Beard C.W., Ball A.O., Wooley E.H., Spindler K.R. Transcription mapping of mouse adenovirus type 1 early region 3. Virology 1990, 175:81-90.
7. Beard C.W., Spindler K.R. Characterization of an 11K protein pro-duced by early region 3 of mouse adenovirus type 1. Virology 1995, 208:457-466.
8. Beard C.W., Spindler K.R. Analysis of early region 3 mutants of mouse adenovirus type 1. J. Virol. 1996, 70:5867-5874.
9. Bergelson J.M., Cunningham J.A., Droguett G., et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323.
10. Bergelson J.M., Krithivas A., Celi L., et al. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J. Virol. 1998, 72:415-419.
11. Berk A.J., Lee F., Harrison T., Williams J., Sharp P.A. Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell 1979, 17:935-944.
12. Blailock Z.R., Rabin E.R., Melnick J.L. Adenovirus endocarditis in mice. Science 1967, 157:69-70.
13. Blanke C., Clark C., Broun E.R., et al. Evolving pathogens in allo-geneic bone marrow transplantation: increased fatal adenoviral infections. Am. J. Med. 1995, 99:326-328.
14. Bresnahan W.A., Shenk T.E. UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc. Natl. Acad. Sci. USA 2000, 97:14506-14511.
15. Cai W., Schaffer P.A. Herpes simplex virus type 1ICP0 regulates expression of immediate-early early and late genes in productively infected cells. J. Virol. 1992, 66:2904-2915.
16. Cai F., Tang D., Weber J.M. Primary structure of the murine adenovirus type 1 proteinase. Biochim. Biophys. Acta 1992, 1129:339-341.
17. Carrigan D.R. Adenovirus infections in immunocompromised patients. Am. J. Med. 1997, 102:71-74.
18. Cauthen A.N. n vitro and in vivo characterization of mouse adenovirus type 1 early region 3 mutants. Ph.D. dissertation 1998, University of Georgia, Athens.
19. Cauthen A.N., Brown C.C., Spindler K.R. In vitro and in vivo characterization of a mouse adenovirus type 1 early region 3 mutant. J. Virol. 1999, 73:8640-8646.
20. Cauthen A.N., Spindler K.R. Sequence of the mouse adenovirus type-1 DNA encoding the 100-kDa 33-kDa and DNA binding proteins. Gene 1996, 168:183-187.
21. Cauthen A.N., Spindler K.R. Construction of mouse adenovirus type 1 mutants. Adenovirus Methods and Protocols 1999, 85-103. Humana Press, Totowa NJ.
22. Cauthen A.N., Spindler K.R. Novel expression of mouse adenovirus type 1 early region 3 gp11K at late times after infection. Virology 1999, 259:119-128.
23. Challberg M.D., Rawlins D.R. Template requirements for the ini-tiation of adenovirus DNA replication. Proc. Natl. Acad. Sci. USA 1984, 81:100-104.
24. Charles P.C., Chen X., Horwitz M.S., Brosnan C.F. Differential chemokine induction by the mouse adenovirus type-1 in the central nervous system of susceptible and resistant strains of mice. J. Neurovirol. 1999, 5:55-64.
25. Charles P.C., Guida J.D., Brosnan C.F., Horwitz M.S. Mouse adenovirus type-1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice. Virology 1998, 245:216-228.
26. Chen J., Silverstein S. Herpes simplex viruses with mutations in the gene encoding ICP0 are defective in gene expression. J. Virol. 1992, 66:2916-2927.
27. Coutelier J.-P., Coulie P.G., Wauters P., Heremans H., van der Logt J.T.M. In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J. Virol. 1990, 64:5383-5388.
28. Coutelier J.-P., van Broeck J., Wolf S.F. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 1995, 69:1955-1958.
29. Coutelier J.-P., van der Logt J.T.M., Heessen F.W.A., Vink A., Van Snick J. Virally induced modulation of murine IgG antibody sub-classes. J. Exp. Med. 1988, 168:2373-2378.
30. Coutelier J.-P, van der Logt J.T.M., Heessen F.W.A., Warnier G., Van Snick J. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 1987, 165:64-69.
31. Davison A.J., Benko M., Harrach B. Genetic content and evolu-tion of adenoviruses. J. Gen. Virol. 2003, 84:2895-2908.
32. de Jong P.J., Valderrama G., Spigland L, Horwitz M.S. Adenovirus isolates from urine of patients with acquired immunodeficiency syndrome. Lancet 1983, 1:1293-1294.
33. Dyson N., Guida P., McCall C., Harlow E. Adenovirus El A makes two distinct contacts with the retinoblastoma protein. J. Virol. 1992, 66:4606-4611.
34. Dyson N., Guida P., Miinger K., Harlow E. Homologous sequence in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol. 1992, 66:6893-6902.
35. Egan C., Jelsma T.N., Howe J.A., Bayley S.T., Ferguson B., Branton P.E. Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5. Mol. Cell Biol. 1988, 8:3955-3959.
36. Everett R.D., Boutell C., Orr A. Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0. J. Virol. 2004, 78:1763-1774.
37. Fang L.J.L., Stevens A.J., Berk, Spindler K.R. Requirement of Sur2 for efficient mouse adenovirus type 1 replication. J. Virol. 2004, 78:12888-12900.
38. Fang L., Spindler K.R. E1A-CR3 Interaction-dependent and-inde-pendent functions of mSur2 in viral replication of early region 1A mutants of mouse adenovirus type 1. J. Virol. 2005, 79:3267-3276.
39. Fessier S.P., Delgado-Lopez F., Horwitz M.S. Mechanisms of E3 modulation of immune and inflammatory responses. Curr. Top. Microbiol. Immunol. 2004, 273:113-135.
40. Flomenberg P., Babbitt J., Drobyski W.R., et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J. Inf. Dis. 1994, 169:775-781.
41. Fox J.P., Brandt C.D., Wasserman F.E., et al. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excre-tion patterns antibody response efficiency of surveillance patterns of infection and relation to illness. Am. J. Epidemiology 1969, 89:25-50.
42. Gallimore P.H., Turnell A.S. Adenovirus E1A: remodelling the host cell a life or death experience. Oncogene 2001, 20:7824-7835.
43. Garnett C.T., Erdman D., Xu W., Gooding L.R. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J. Virol. 2002, 76:10608-10616.
44. Gavin P.J., Katz B.Z. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 2002, 110:1-8.
45. Gaynor R.B., Berk A.J. Cis-acting induction of adenovirus tran-scription. Cell 1983, 33:683-693.
46. Gaynor R.B., Tsukamoto A., Montell C., Berk A.J. Enhanced expression of adenovirus transforming proteins. J. Virol. 1982, 44:276-285.
47. Ginder D.R. Increased susceptibility of mice infected with mouse adenovirus to Escherichia coli-induced pyelonephritis. J. Exp. Med. 1964, 120:1117-1128.
48. Ginsberg H.S., Moldawer L.L., Sehgal P.B., et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 1991, 88:1651-1655.
49. Gomez-Roman V.R., Robert-Guroff M. Adenoviruses as vectors for HIV vaccines. AIDS Rev. 2003, 5:178-185.
50. Gottlieb K., Villarreal L.P. The distribution and kinetics of poly-omavirus in lungs of intranasally infected newborn mice. Virology 2000, 266:52-65.
51. Guida J.D., Fejer G., Pirofski L.-A., Brosnan C.F., Horwitz M.S. Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J. Virol. 1995, 69:7674-7681.
52. Gutch M.J., Reich N.C. Repression of the interferon signal trans-duction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. USA 1991, 88:7913-7917.
53. Hale G.A., Heslop H.E., Krance R.A., et al. Adenovirus infection after pediatrie bone marrow transplantation. Bone Marrow Transplant 1999, 23:277-282.
54. Hamelin C., Jacques C., Lussier G. Genome typing of mouse adenoviruses. J. Clin. Microbiol. 1988, 26:31-33.
55. Hamelin C., Lussier G. Genotypic differences between the mouse adenovirus strains FL and K87. Experientia 1988, 44:65-66.
56. Harlow E., Whyte P., Franza B.R.J., Schley C. Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol. Cell. Biol. 1986, 6:1579-1589.
57. Hart M.K. Vaccine research efforts for filoviruses. Int. J. Parasitol. 2003, 33:583-595.
58. Hartley J.W., Rowe W.P. A new mouse virus apparently related to the adenovirus group. Virology 1960, 11:645-647.
59. Hashimoto K., Sugiyama T., Saski S. An adenovirus isolated from the feces of mice. I. Isolation and identification. Jpn. J. Microbiol. 1966, 10:115-125.
60. Hashimoto K., Sugiyama T., Yoshikawa M., Sasaki S. Intestinal resistance in the experimental enteric infection of mice with a mouse ade-novirus. I. Growth of the virus and appearance of a neutralizing substance in the intestinal tract. Japan. J. Microbiol. 1970, 14:381-395.
61. Heck F.C., Sheldon W.G., Gleiser C.A. Pathogenesis of experimentally produced mouse adenovirus infection in mice. Am. J. Vet. Res. 1972, 33:841-846.
62. Hilleman M.R., Werner J.R. Recovery of a new agent from patients with acute respiratory illness. Proc. Soc. Exp. Biol. Med. 1954, 85:183-188.
63. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 1967, 26:365-369.
64. Horwitz M.S. Adenoviruses. In Fields Virology 2001, 2301-2326. Lippincott Williams & Wilkins, Philadelphia. 4th ed. D.M. Knipe, P.M. Howley (Eds.).
65. Ikeda M., Nevins J.R. Identification of distinct roles for separate El A domains in disruption of E2F complexes. Mol. Cell. Biol. 1993, 13:7029-7035.
66. Imperiale M.J., Kao H.-T., Feldman L.T., Nevins J.R., Strickland S. Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity. Mol. Cell. Biol. 1984, 4:867-874.
67. Imperiale M.J., Kochanek S. Adenovirus vectors: biology design and production. Curr. Top. Microbiol. Immunol. 2004, 273:335-357.
68. 51Cr release test in mice infected with mouse adenovirus. Infect. Immun. 1978, 20:1-5.
69. Inada T., Uetake H. Cell-mediated immunity to mouse adenovirus infection: macrophage migration inhibition test. Microbiol. Immunol. 1978, 22:391-401.
70. Inada T., Uetake H. Nature and specificity of effector cells in cell-mediated cytolysis of mouse adenovirus-infected cells. Infect. Immun. 1978, 22:119-124.
71. International Committee on Taxonomy of Viruses Family Adenoviridae. Virus Taxonomy: Classification and Nomenclature of Viruses: Seventh Report of the International Committee on Taxonomy of Viruses 2000, 227-238. Academic Press, San Diego. M.H. V. van Regenmortel, C.M. Fauquet, D.H.L. Bishop (Eds.).
72. Ishibashi M., Yasue H. Adenoviruses of animals. The Adenoviruses 1984, 497-562. Plenum Press, New York. H.S. Ginsberg (Ed.).
73. Jacques C., Cousineau L., D'Amours B., Lussier G., Hamelin C. Molecular cloning physical mapping and cross-hybridization of the murine adenovirus type 1 and type 2 genomes. J. Gen. Virol. 1994, 75:1311-1317.
74. Jacques C., D'Amours B., Hamelin C. Genetic relationship between mouse adenovirus-2 (strain K87) and human adenovirus-2. FEMS Microbiol. Lett. 1994, 115:7-11.
75. Jones N.C., Shenk T. An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc. Natl. Acad. Sci. USA 1979, 76:3665-3669.
76. Kajon A.E., Brown C.C., Spindler K.R. Distribution of mouse adenovirus type 1 in intraperitoneally and intranasally infected adult outbred mice. J. Virol. 1998, 72:1219-1223.
77. Kajon A.E., Mistchenko A.S., Videla C., Hortal M., Wadell G., AvendaÒo L.F. Molecular epidemiology of adenovirus acute lower respiratory infections of children in the south cone of South America (1991-1994). J. Med. Virol. 1996, 48:151-156.
78. Kajon A.E., Spindler K.R. Mouse adenovirus type 1 replication in vitro is resistant to interferon. Virology 2000, 274:213-219.
79. Kaplan C., Healing T.D., Evans N., Healing L., Prior A. Evidence of infection by viruses in small British field rodents. J. Hyg. 1980, 84:285-294.
80. Khan W.N., Alt F.W., Gerstein R.M., et al. Defective B cell devel-opment and function in Btk-deficient mice. Immunity 1995, 3:283-299.
81. Kojaoghlanian T., Flomenberg P., Horwitz M.S. The impact of adenovirus infection on the immunocompromised host. Rev. Med. Virol. 2003, 13:155-171.
82. Kraft V., Meyer B. Seromonitoring in small laboratory animal colonies. A five year survey: 1984-1988. Z. Versuchstierkd. 1990, 33:29-35.
83. Kring S.C., Ball A.O., Spindler K.R. Transcription mapping of mouse adenovirus type 1 early region 4. Virology 1992, 190:248-255.
84. Kring S.C., King C.S., Spindler K.R. Susceptibility and signs associated with mouse adenovirus type 1 infection of adult outbred Swiss mice. J. Virol. 1995, 69:8084-8088.
85. Kring S.C., Spindler K.R. Sequence of mouse adenovirus type 1 DNA encoding the amino terminus of protein IVa2. Nucleic Acids Res. 1990, 18:4003.
86. Kring S.C., Spindler K.R. Lack of effect of mouse adenovirus type 1 infection on the cell surface expression of major histocompatibility complex class I antigens. J. Virol. 1996, 70:5495-5502.
87. Lally C., Dörper T., Gröger W., Antoine G., Winnacker E.-L. A size analysis of the adenovirus replicon. EMBO J. 1984, 3:333-337.
88. Larsen S.H., Nathans D. Mouse adenovirus: growth of plaque-purified FL virus in cell lines and characterization of viral DNA. Virology 1977, 82:182-195.
89. Leonard G.T., Sen G.C. Effects of adenovirus E1A protein on interferon-signaling. Virology 1996, 224:25-33.
90. Levine A.J. The adenovirus early proteins. Curr. Top. Microbiol. Immunol. 1984, 110:143-167.
91. Lipps B.V., Mayor H.D. Transplacental infection with adeno-associated virus type 1 in mice. Intervirology 1980, 14:118-123.
92. Lipps B.V., Mayor H.D. Defective parvoviruses acquired via the transplacental route protect mice against lethal adenovirus infection. Infect. Immun. 1982, 37:190-204.
93. Look D.C., Roswit W.T., Frick A.G., et al. Direct suppression of Statl function during adenoviral infection. Immunity 1998, 9:871-880.
94. Lukashok S.A., Horwitz M.S. Adenovirus. Persistent Viral Infections 1999, 147-164. John Wiley & Sons, New York. R. Ahmed, I. Chen (Eds.).
95. Lussier G., Smith A.L., Guénette D., Descôteaux J.-P. Serological relationship between mouse adenovirus strains FL and K87. Lab. Anim. Sci. 1987, 37:55-57.
96. Margolis G., Kilham L., Hoenig E.M. Experimental adenovirus infection of the mouse adrenal gland. I. Light microscopic observations. Am. J. Pathol. 1974, 75:363-372.
97. Meissner J.D., Hirsch G.N., LaRue E.A., Fulcher R.A., Spindler K.R. Completion of the DNA sequence of mouse adenovirus type 1: sequence of E2B L1 and L2 (18-51 map units). Virus Res. 1997, 51:53-64.
98. Mombaerts P., Clarke A.R., Rudnicki M.A., et al. Mutations in T-cell antigen receptor genes α and β block thymocyte development at dif-ferent stages. Nature 1992, 360:225-231.
99. Moore M.L., Brown C.C., Spindler K.R. T cells cause acute immunopathology and are required for long-term survival in mouse ade-novirus type 1-induced encephalomyelitis. J. Virol. 2003, 77:10060-10070.
100. Moore M.L., McKissic E.L., Brown C.C., Wilkinson J.E., Spindler K.R. Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase. J. Virol. 2004, 78:5584-5590.
101. Moran E., Mathews M.B. Multiple functional domains in the adenovirus E1A gene. Cell 1987, 48:177-178.
102. Moro D., Lloyd M.L., Smith A.L., Shellam G.R., Lawson M.A. Murine viruses in an island population of introduced house mice and endemic short-tailed mice in western Australia. J. Wildl. Dis. 1999, 35:301-310.
103. Müller U., Steinhoff U., Reis L.F.L., et al. Functional role of type I and type II interferons in antiviral defense. Science 1994, 264:1918-1921.
104. Nevins J.R. Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell 1981, 26:213-220.
105. Oliveira S.A., Shenk T.E. Murine cytomegalovirus M78 protein a G protein-coupled receptor homologue is a constituent of the virion and facilitates accumulation of immediate-early viral mRNA. Proc. Natl. Acad. Sci. USA 2001, 98:3237-3242.
106. Otten J.A., Tennant R.W. Mouse adenovirus. The Mouse in Biomedical Research 1982, vol. II:335-340. Academic Press, New York.
107. Pacini D.L., Dubovi E.J., Clyde W.A. A new animal model for human respiratory tract disease due to adenovirus. J. Infect. Dis. 1984, 150:92-97.
108. Parker J.C., Tennant R.W., Ward T.G. Prevalence of viruses in mouse colonies. Nat. Cancer Inst. Monogr. 1966, 20:25-36.
109. Philipson L., Lonberg-Holm K., Petterson U. Virus-receptor interaction in an adenovirus system. J. Virol. 1968, 2:1064-1075.
110. Pirofski L., Horwitz M.S., Scharff M.D., Factor S.M. Murine adenovirus infection of SCID mice induces hepatic lesions that resemble human Reye syndrome. Proc. Natl. Acad. Sci. USA 1991, 88:4358-4362.
111. Raviprakash K.S., Grunhaus A., El Kholy M.A., Horwitz M.S. The mouse adenovirus type 1 contains an unusual E3 region. J. Virol. 1989, 63:5455-5458.
112. Reeves W.C., Serivani R.P., Pugh W.E., Rowe W.P. Recovery of an adenovirus from a feral rodent. Peromyscus maniculatus. Proc. Soc. Exp. Biol. Med. 1967, 124:1173-1175.
113. Richter C.B. Mouse adenovirus K virus pneumonia virus of mice. Viral and Mycoplasmal Infections of Laboratory Rodents: Effects on Biomedical Research 1986, 137-161. Academic Press, New York. P.N. Bhatt, R.O. Jacoby, H.C.I. Morse, A.E. New (Eds.).
114. Rowe P.W., Hartley J.W. A general review of the adenoviruses. Ann. New York Acad. Sci. 1962, 101:466-474.
115. Rowe W.P., Huebner R.J., Gilmore L.K., Parrot R.H., Ward T.G. Isolation of a cytopathic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc. Soc. Exp. Biol. Med. 1953, 84:570-573.
116. Sharon N., Pollard M. Propagation of mouse adenovirus on cell lines of human origin. Nature 1964, 202:1139-1140.
117. Shenk T.E. Adenoviridae: the viruses and their replication. Fields Virology 2001, vol. 2:2265-2300. Lippincott Williams & Wilkins, Philadelphia. 4th ed. D.M. Knipe, P.M. Howley (Eds.).
118. Singleton G.R., Smith A.L., Shellam G.R., Fitzgerald N., Müller W.J. Prevalence of viral antibodies and helminths in field populations of house mice (Mus domesticus) in southeastern Australia. Epidemiol. Infect. 1993, 110:399-417.
119. Smith A.L., Barthold S.W. Factors influencing susceptibility of laboratory rodents to infection with mouse adenovirus strains K87 and FL. Arch. Virol. 1987, 95:143-148.
120. Smith A.L., Singleton G.R., Hansen G.M., Shellam G. A sero-logic survey for viruses and Mycoplasma pulmonis among wild house mice (Mus domesticus) in southeastern Australia. J. Wildl. Dis. 1993, 29:219-229.
121. Smith A.L., Winograd D.F., Burrage T.G. Comparative biolog-ical characterization of mouse adenovirus strains FL and K87 and seroprevalence in laboratory rodents. Arch. Virol. 1986, 91:233-246.
122. Smith K., Brown C.C., Spindler K.R. The role of mouse ade-novirus type 1 early region 1A in acute and persistent infections in mice. J. Virol. 1998, 72:5699-5706.
123. Smith K., Spindler K.R. Murine adenovirus. Persistent Viral Infections 1999, 477-484. John Wiley & Sons, New York. R. Ahmed, I. Chen (Eds.).
124. Smith K., Ying B., Ball A.O., Beard C.W., Spindler K.R. Interaction of mouse adenovirus type 1 early region 1A protein with cellular proteins pRb and p107. Virology 1996, 224:184-197.
125. Song B., Hu S.-L., Darai G., Spindler K.R., Young C.S.H. Conservation of DNA sequence in the predicted major late promoter regions of selected mastadenoviruses. Virology 1996, 220:390-401.
126. Song B., Spindler K.R., Young C.S.H. Sequence of the mouse adenovirus serotype-1 DNA encoding the precursor to capsid protein VI. Gene 1995, 152:279-280.
127. Song B., Young C.S.H. Functional characterization of the major late promoter of mouse adenovirus type 1. Virology 1997, 235:109-117.
128. Spindler K.R., Fang L., Moore M.L., Brown C.C., Hirsch G.N., Kajon A.K. SJL/J mice are highly susceptible to infection by mouse adenovirus type 1. J. Virol. 2001, 75:12039-12046.
129. Szomolanyi-Tsuda E., Welsh R.M. T-cell-independent antiviral antibody responses. Curr. Op. Immunol. 1998, 10:431-435.
130. Takeuchi A., Hashimoto K. Electron microscope study of experi-mental enteric adenovirus infection in mice. Infect. Immun. 1976, 13:569-580.
131. Tamanoi F., Stillman B.W. Initiation of adenovirus DNA replica-tion in vitro requires a specific DNA sequence. Proc. Natl. Acad. Sci. USA 1983, 80:6446-6450.
132. Temple M., Antoine G., Delius H., Stahl S., Winnacker E.-L. Replication of mouse adenovirus strain FL DNA. Virology 1981, 109:1-12.
133. Thomas C.E., Ehrhardt A., Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 2003, 4:346-358.
134. Tomko R.P., Xu R., Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B cox-sackieviruses. Proc. Natl. Acad. Sci. USA 1997, 94:3352-3356.
135. Trentin J.J., Van Hoosier G.L., Shields J., Stephens K., Stenback W.A., Parker J.C. Limiting the viral spectrum of the laboratory mouse. Nat. Cancer Inst. Monogr. 1966, 20:147-160.
136. Umehara K., Hirakawa M., Hashimoto K. Fluctuation of antivi-ral resistance in the intestinal tracts of nude mice infected with a mouse adenovirus. Microbiol. Immunol. 1984, 28:679-690.
137. Umehara K., Tazume S., Hashimoto K. Analysis of antiviral resistance in the intestinal tracts of nude mice infected with a mouse ade-novirus. Tokai J. Exp. Clin. Med. 1987, 12:125-134.
138. van der Veen J., Mes A. Experimental infection with mouse adenovirus in adult mice. Arch. Gesamte Virusforsch. 1973, 42:235-241.
139. Walls T., Shankar A.G., Shingadia D. Adenovirus: an increas-ingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect. Dis. 2003, 3:79-86.
140. Weber J.M., Cai F., Murali R., Burnett R.M. Sequence and structural analysis of murine adenovirus type 1 hexon. J. Gen. Virol. 1994, 75:141-147.
141. Welton A.R., Chesler E.J., Sturkie C., Jackson A.U., Hirsch G.N., Spindler K.R. Identification of quantitative trait loci for susceptibil-ity to mouse adenovirus type 1. J. Virol. 2005, 79:11517-11522.
142. Whyte P., Williamson N.M., Harlow E. Cellular targets for trans-formation by the adenovirus E1A proteins. Cell 1989, 56:67-75.
143. 5 promote adenovirus internalization but not virus attachment. Cell 1993, 73:309-319.
144. Wigand R. Age and susceptibility of Swiss mice for mouse adenovirus strain FL. Arch. Virol. 1980, 64:349-358.
145. Wigand R., Gelderblom H., Özel M. Biological and biophysical characteristics of mouse adenovirus strain FL. Arch. Virol. 1977, 54:131-142.
146. Winters A.L., Brown H.K. Duodenal lesions associated with adenovirus infection in athymic "nude" mice. Proc. Soc. Exp. Bio. Med. 1980, 164:280-286.
147. Winters A.L., Brown H.K., Carlson J.K. Interstitial pneumonia induced by a plaque-type variant of mouse adenovirus. Proc. Soc. Exp. Biol. Med. 1981, 167:359-364.
148. Wold W.S.M., Gooding L.R. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 1991, 184:1-8.
149. Yee S.-P., Branton P.E. Analysis of multiple forms of human adenovirus type 5 E1A polypeptides using an antipeptide antiserum specific for the amino terminus. Virology 1985, 146:315-322.
150. Yee S.-P., Branton P.E. Detection of cellular proteins associated with human ade-novirus type 5 early region 1A polypeptides. Virology 1985, 147:142-153.
151. Yee S.-P., Rowe D.T., Tremblay M.L., McDermott M., Branton P.E. Identification of human adenovirus early region 1 products using antisera against synthetic peptides corresponding to the predicted carboxy termini. J. Virol. 1983, 46:1013-1033.
152. Ying B., Smith K., Spindler K.R. Mouse adenovirus type 1 early region 1A is dispensable for growth in cultured fibroblasts. J. Virol. 1998, 72:6325-6331.
153. Zinkernagel R.M., Hengartner H. Regulation of the immune response by antigen. Science 2001, 293:251-253.